Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-011391
Filing Date
2020-11-27
Accepted
2020-11-27 18:09:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 35943
2 filename2.txt TEXT-EXTRACT 13600
  Complete submission text file 0000000000-20-011391.txt   63804
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filed for) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations